SCOPUS 정보 검색 플랫폼

OncoImmunology

Volumn 1, Issue 2, 2012, Pages 234-236

STATing the importance of immune modulation by platinum chemotherapeutics

(3) Hato, Stanleyson V a de Vries, I Jolanda M a Lesterhuis, W Joost a

a RADBOUD UNIVERSITY MEDICAL CENTER (Netherlands)

Author keywords

Dendritic cell; Immune modulation; PD L2; Platinum chemotherapy; STAT6

Indexed keywords

CISPLATIN; INTERLEUKIN 4; OXALIPLATIN; PLATINUM COMPLEX; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; STAT6 PROTEIN;

APOPTOSIS; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; DENDRITIC CELL; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECURRENCE FREE SURVIVAL; TUMOR MICROENVIRONMENT;

EID: 84861085067 PISSN: 21624011 EISSN: 2162402X Source Type: Journal
DOI: 10.4161/onci.1.2.18126 Document Type: Note

Times cited : (31)

References (10)

1
- 34948820602
- Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
- Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13:1050-9; http://dx.doi.org/10.1038/nm1622
- (2007) Nat Med , vol.13 , pp. 1050-1059
- Apetoh, L.¹ Ghiringhelli, F.² Tesniere, A.³ Obeid, M.⁴ Ortiz, C.⁵ Criollo, A.⁶

2
- 79961011492
- Cancer immunotherapy - revisited
- Lesterhuis WJ, Haanen JB, Punt CJ. Cancer immunotherapy - revisited. Nat Rev Drug Discov 2011; 10:591-600; http://dx.doi.org/10.1038/nrd3500
- (2011) Nat Rev Drug Discov , vol.10 , pp. 591-600
- Lesterhuis, W.J.¹ Haanen, J.B.² Punt, C.J.³

3
- 77951178310
- Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
- Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho HI, Antonia S, et al. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. J Clin Invest 2010; 120:1111-24; http://dx.doi.org/10.1172/JCI40269
- (2010) J Clin Invest , vol.120 , pp. 1111-1124
- Ramakrishnan, R.¹ Assudani, D.² Nagaraj, S.³ Hunter, T.⁴ Cho, H.I.⁵ Antonia, S.⁶

4
- 79961016549
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
- Lesterhuis WJ, Punt CJ, Hato SV, Eleveld-Trancikova D, Jansen BJ, Nierkens S, et al. Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice. J Clin Invest 2011; 121:3100-8; http://dx.doi.org/10.1172/JCI43656
- (2011) J Clin Invest , vol.121 , pp. 3100-3108
- Lesterhuis, W.J.¹ Punt, C.J.² Hato, S.V.³ Eleveld-Trancikova, D.⁴ Jansen, B.J.⁵ Nierkens, S.⁶

5
- 42649125225
- PD-1 and its ligands in tolerance and immunity
- Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-704; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090331
- (2008) Annu Rev Immunol , vol.26 , pp. 677-704
- Keir, M.E.¹ Butte, M.J.² Freeman, G.J.³ Sharpe, A.H.⁴

6
- 34249000341
- Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development
- Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, et al. Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med 2007; 204:1037-47; http://dx.doi.org/10.1084/jem.20061120
- (2007) J Exp Med , vol.204 , pp. 1037-1047
- Aspord, C.¹ Pedroza-Gonzalez, A.² Gallegos, M.³ Tindle, S.⁴ Burton, E.C.⁵ Su, D.⁶

7
- 20244384862
- Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
- Ohigashi Y, Sho M, Yamada Y, Tsurui Y, Hamada K, Ikeda N, et al. Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer. Clin Cancer Res 2005; 11:2947-53; http://dx.doi.org/10.1158/1078-0432.CCR-04-1469
- (2005) Clin Cancer Res , vol.11 , pp. 2947-2953
- Ohigashi, Y.¹ Sho, M.² Yamada, Y.³ Tsurui, Y.⁴ Hamada, K.⁵ Ikeda, N.⁶

8
- 77953176278
- EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis
- Wang CG, Ye YJ, Yuan J, Liu FF, Zhang H, Wang S. EZH2 and STAT6 expression profiles are correlated with colorectal cancer stage and prognosis. World J Gastroenterol 2010; 16:2421-7; http://dx.doi.org/10.3748/wjg.v16.i19.2421
- (2010) World J Gastroenterol , vol.16 , pp. 2421-2427
- Wang, C.G.¹ Ye, Y.J.² Yuan, J.³ Liu, F.F.⁴ Zhang, H.⁵ Wang, S.⁶

9
- 79956227340
- STAT6 expression in glioblastoma promotes invasive growth
- Merk BC, Owens JL, Lopes MB, Silva CM, Hussaini IM. STAT6 expression in glioblastoma promotes invasive growth. BMC Cancer 2011; 11:184; http://dx.doi.org/10.1186/1471-2407-11-184
- (2011) BMC Cancer , vol.11 , pp. 184
- Merk, B.C.¹ Owens, J.L.² Lopes, M.B.³ Silva, C.M.⁴ Hussaini, I.M.⁵

10
- 78049265321
- A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients
- Lesterhuis WJ, de Vries IJ, Aarntzen EA, de Boer A, Scharenborg NM, van de Rakt M, et al. A pilot study on the immunogenicity of dendritic cell vaccination during adjuvant oxaliplatin/capecitabine chemotherapy in colon cancer patients. Br J Cancer 2010; 103:1415-21; http://dx.doi.org/10.1038/sj.bjc.6605935
- (2010) Br J Cancer , vol.103 , pp. 1415-1421
- Lesterhuis, W.J.¹ de Vries, I.J.² Aarntzen, E.A.³ de Boer, A.⁴ Scharenborg, N.M.⁵ van de Rakt, M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.